Protagonist Therapeutics Stock Predictions

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Buy

PTGX
Protagonist Therapeutics

Last Price:

$44.17

Seasonality Move:

34.62%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Protagonist Therapeutics Stock Forecast

Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 52.8% based on the past 8 years of stock performance.
Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Is Protagonist Therapeutics Stock Undervalued?

The current Protagonist Therapeutics [PTGX] share price is $45.27. The Score for PTGX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Protagonist Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 52.8% based on the past 8 years of stock performance.

Protagonist Therapeutics Stock Rating

Buy

Protagonist Therapeutics (PTGX) is a Buy

Is Protagonist Therapeutics overpriced?

Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

Protagonist Therapeutics Stock Price History

Is PTGX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

protagonist-inc.com

52-Week Data

52-Week High:

60.60

52-Week Low:

27.00

Prediction Charts

Market Cap:

2.8B

Price in USD:

45.27

Volume:

Beta:

1.95

Technical Analysis

SMA50:

46.42

SMA100:

42.38

SMA200:

42.76

52-Wk Change:

60.36%

Stock Predictions

Is Protagonist Therapeutics stock public?

Yes, Protagonist Therapeutics is a publicly traded company.
What is the Protagonist Therapeutics stock quote today?

The Protagonist Therapeutics stock price is 45.27 USD today.
How to buy Protagonist Therapeutics stock online?

You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-23	47.13	46.16	47.35	45.73
Apr-24	45.96	44.85	46.06	44.27
Apr-25	44.36	44.49	44.84	43.62
Apr-28	44.49	44.39	45.50	44.08
Apr-29	44.16	45.62	46.00	43.69
Apr-30	45.25	45.82	46.02	44.22
May-1	45.23	44.99	45.63	43.49
May-2	45.05	45.51	46.12	44.82
May-5	45.39	44.28	45.53	44.20
May-6	43.86	42.01	44.23	41.74
May-7	41.77	43.09	43.20	41.29
May-8	42.60	43.92	44.37	41.60
May-9	44.15	42.97	45.43	42.85
May-12	43.77	45.27	45.83	43.75

Protagonist Therapeutics Earnings

Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Protagonist Therapeutics Forecast Revenue Growth

Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.09 per share, a decrease this year of $4.05 per share, and an increase next year of $0.28 per share.

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.